FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2958660410> ?p ?o ?g. }

• W2958660410 endingPage "767" @default.
• W2958660410 startingPage "760" @default.
• W2958660410 abstract "What is known and objective The aim of this study was to evaluate the appropriateness and clinical outcomes of edoxaban use, and to determine the role of clinical pharmacists in improving the efficacy and safety of edoxaban use. Methods A retrospective study was performed by using an electronic medical record and anticoagulation clinical data from 600 patients who received edoxaban from 1 March 2016 to 16 July 2017 at a tertiary teaching university hospital. The appropriateness of edoxaban use was assessed using eight criteria based on drug use evaluation criteria developed by the American Society of Health-System Pharmacists drug use evaluation guidelines, details in Korea Food and Drug Administration approval of edoxaban. Clinical outcomes were evaluated between the appropriately prescribed and inappropriately prescribed groups regarding the incidence of thrombosis and bleeding episodes. Results and discussion After excluding 86 patients due to the inability to assess renal function, 514 were eligible. Appropriate use was found in 294 patients (57.2%). The most frequent inappropriate use of edoxaban was dose adjustment (60.8%) in accordance with the dosing recommendation in patients with renal insufficiency (creatinine clearance [CrCl] of 15-50 mL/min) and a low body weight of <60 kg. Moreover, there were three cases of edoxaban use in patients with prosthetic heart valves and moderate-to-severe mitral stenosis, and 15 cases of non-valvular atrial fibrillation in patients with CrCl >95 mL/min in whom edoxaban use is not recommended. Furthermore, we found that the factors related to the appropriateness of edoxaban use were <60 kg body weight (adjusted odds ratio [OR]: 0.310; confidence interval [CI]: 0.197-0.488) and CrCl <50 mL/min (adjusted OR: 0.629; CI: 0.404-0.980). There were 45 events (8.75%) of any bleeding, 9 (1.8%) of stroke/transient ischaemic attack (TIA) and four events (0.8%) of deep vein thrombosis (DVT)/pulmonary embolism (PE). However, there was no difference between the appropriately prescribed group (294 patients) and inappropriately prescribed group (220 patients) in the incidence of bleeding events (27 [9.2%] vs 18 [8.2%]), stroke/TIA (7 [2.4%] vs 2 [0.9%]) and DVT/PE (2 [0.7%] vs 2 [0.9%]), respectively. What is new and conclusion Although edoxaban has a broad therapeutic window that does not require routine monitoring, it should be cautiously used in patients with renal insufficiency (CrCl <50 mL/min) and body weight <60 kg." @default.
• W2958660410 created "2019-07-23" @default.
• W2958660410 creator A5004277197 @default.
• W2958660410 creator A5005762530 @default.
• W2958660410 creator A5025751424 @default.
• W2958660410 creator A5027843266 @default.
• W2958660410 creator A5046643663 @default.
• W2958660410 creator A5069471195 @default.
• W2958660410 creator A5077552269 @default.
• W2958660410 creator A5083541090 @default.
• W2958660410 date "2019-07-10" @default.
• W2958660410 modified "2023-09-27" @default.
• W2958660410 title "Factors related to inappropriate edoxaban use" @default.
• W2958660410 cites W1787777811 @default.
• W2958660410 cites W1982653307 @default.
• W2958660410 cites W2054850811 @default.
• W2958660410 cites W2096246254 @default.
• W2958660410 cites W2101963942 @default.
• W2958660410 cites W2117983655 @default.
• W2958660410 cites W2127985968 @default.
• W2958660410 cites W2160625453 @default.
• W2958660410 cites W2162586165 @default.
• W2958660410 cites W2225937646 @default.
• W2958660410 cites W2263934434 @default.
• W2958660410 cites W2362016459 @default.
• W2958660410 cites W2492552840 @default.
• W2958660410 cites W2596193706 @default.
• W2958660410 cites W2622276831 @default.
• W2958660410 cites W2790375504 @default.
• W2958660410 cites W2792857103 @default.
• W2958660410 cites W2800611541 @default.
• W2958660410 cites W2810365028 @default.
• W2958660410 cites W2888940848 @default.
• W2958660410 doi "https://doi.org/10.1111/jcpt.12999" @default.
• W2958660410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31292978" @default.
• W2958660410 hasPublicationYear "2019" @default.
• W2958660410 type Work @default.
• W2958660410 sameAs 2958660410 @default.
• W2958660410 citedByCount "5" @default.
• W2958660410 countsByYear W29586604102020 @default.
• W2958660410 countsByYear W29586604102021 @default.
• W2958660410 countsByYear W29586604102023 @default.
• W2958660410 crossrefType "journal-article" @default.
• W2958660410 hasAuthorship W2958660410A5004277197 @default.
• W2958660410 hasAuthorship W2958660410A5005762530 @default.
• W2958660410 hasAuthorship W2958660410A5025751424 @default.
• W2958660410 hasAuthorship W2958660410A5027843266 @default.
• W2958660410 hasAuthorship W2958660410A5046643663 @default.
• W2958660410 hasAuthorship W2958660410A5069471195 @default.
• W2958660410 hasAuthorship W2958660410A5077552269 @default.
• W2958660410 hasAuthorship W2958660410A5083541090 @default.
• W2958660410 hasBestOaLocation W29586604101 @default.
• W2958660410 hasConcept C120665830 @default.
• W2958660410 hasConcept C121332964 @default.
• W2958660410 hasConcept C126322002 @default.
• W2958660410 hasConcept C159641895 @default.
• W2958660410 hasConcept C177713679 @default.
• W2958660410 hasConcept C2776301958 @default.
• W2958660410 hasConcept C2777288759 @default.
• W2958660410 hasConcept C2778810321 @default.
• W2958660410 hasConcept C2779161974 @default.
• W2958660410 hasConcept C2780035454 @default.
• W2958660410 hasConcept C2780290652 @default.
• W2958660410 hasConcept C61511704 @default.
• W2958660410 hasConcept C71924100 @default.
• W2958660410 hasConcept C98274493 @default.
• W2958660410 hasConceptScore W2958660410C120665830 @default.
• W2958660410 hasConceptScore W2958660410C121332964 @default.
• W2958660410 hasConceptScore W2958660410C126322002 @default.
• W2958660410 hasConceptScore W2958660410C159641895 @default.
• W2958660410 hasConceptScore W2958660410C177713679 @default.
• W2958660410 hasConceptScore W2958660410C2776301958 @default.
• W2958660410 hasConceptScore W2958660410C2777288759 @default.
• W2958660410 hasConceptScore W2958660410C2778810321 @default.
• W2958660410 hasConceptScore W2958660410C2779161974 @default.
• W2958660410 hasConceptScore W2958660410C2780035454 @default.
• W2958660410 hasConceptScore W2958660410C2780290652 @default.
• W2958660410 hasConceptScore W2958660410C61511704 @default.
• W2958660410 hasConceptScore W2958660410C71924100 @default.
• W2958660410 hasConceptScore W2958660410C98274493 @default.
• W2958660410 hasIssue "5" @default.
• W2958660410 hasLocation W29586604101 @default.
• W2958660410 hasLocation W29586604102 @default.
• W2958660410 hasOpenAccess W2958660410 @default.
• W2958660410 hasPrimaryLocation W29586604101 @default.
• W2958660410 hasRelatedWork W2007116565 @default.
• W2958660410 hasRelatedWork W2096246254 @default.
• W2958660410 hasRelatedWork W2195369357 @default.
• W2958660410 hasRelatedWork W2318391180 @default.
• W2958660410 hasRelatedWork W2889038552 @default.
• W2958660410 hasRelatedWork W3132289493 @default.
• W2958660410 hasRelatedWork W3170409378 @default.
• W2958660410 hasRelatedWork W3173880122 @default.
• W2958660410 hasRelatedWork W4237698359 @default.
• W2958660410 hasRelatedWork W4319019627 @default.
• W2958660410 hasVolume "44" @default.
• W2958660410 isParatext "false" @default.
• W2958660410 isRetracted "false" @default.

• next